Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 46 (RPL21P46)

Target
RPL21P46
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 46 (RPL21P46) is a processed pseudogene related to the ribosomal protein L21 gene family[2][7]. Unlike functional ribosomal proteins (such as RPL21), this pseudogene does not produce a functional protein and has no known biological function, disease association, or therapeutic relevance[7]. In humans, processed pseudogenes like RPL21P46 are common due to gene duplication events but are usually not transcribed or translated into proteins[3][5][7]. The canonical ribosomal protein L21 (RPL21), to which it is related, is a structural component of the large ribosomal 60S subunit, but RPL21P46 itself is not functional[3][5][7]. This is not a therapeutic target—it is a pseudogene, lacking protein-coding function and any known significance as a receptor, enzyme, transporter, or drug target. The entry is technically correct as a gene symbol but incorrect as a therapeutic target or functional molecule[7][2].

Other names
RPL21_14_463RPL21P46
02

Mechanism of action

None

03

Biological functions

None (pseudogenes do not encode functional proteins)
04

Disease associations

None (no known disease association for this pseudogene)

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 46 (RPL21P46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 46 (RPL21P46).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call